NasdaqGS:FTRELife Sciences
Fortrea Executive Shuffle Seeks Stronger Clinical Focus And Turnaround Potential
Fortrea Holdings (NasdaqGS:FTRE) has reshaped its executive ranks, naming Scott Dove, PhD, as President of Clinical Pharmacology Services.
Oren Cohen, MD, is shifting into a more focused position as Chief Medical Officer, concentrating on Fortrea's medical direction.
These changes highlight management's attention on clinical research and development within the broader contract research space.
For investors watching Fortrea at a share price of $10.71, the company is pairing leadership moves...